{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:56:14Z","timestamp":1785419774724,"version":"3.56.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Previous studies indicated that the Fibrosis-4 Index (FIB-4), an evaluation metric for liver fibrosis, is associated with adverse outcomes in coronary artery disease. However, the correlation between FIB-4 and myocardial infarction (MI) in Chinese patients with Type 2 Diabetes Mellitus (T2DM) has not been well-defined. Thus, this study aims to elucidate the association between FIB-4 and MI in Chinese T2DM patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cross-sectional data were collected from T2DM patients at two hospitals in China, designated as the discovery and validation centers. The exposure variable, FIB-4 index, was derived from patient age, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and platelet count. This index was stratified into four distinct clusters via k-means clustering analysis. The primary outcome was defined as the incidence of co-occurring MI. Logistic and restricted cubic spline regression was conducted to assess the association between the FIB-4 index and MI in Chinese T2DM patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the discovery phase, data were analyzed from 2,980 T2DM patients, including 1,114 females (37.38%), with 58 years average age (SD: 10.4). Among them, 190 were also MI patients. Based on the fully adjusted logistic regression analysis, the odds ratio (OR) for the second cluster was 1.00 (95% CI, 0.60-1.40); for the third cluster, it was 1.94 (95% CI, 1.32-2.57), and for the poorest controlled cluster it was 16.18 (95% CI, 14.97-17.39) in comparison to the best-controlled cluster of FIB-4. Restricted cubic spline regression revealed a linear relationship between the FIB-4 index and MI risk. Subgroup analysis demonstrated that this association was significant in elderly adults, females with high BMI, and those with comorbidities such as hypertension, coronary artery disease, and chronic heart failure. These findings yield consistent results in the validation set (n = 224).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Among Chinese patients with T2DM, elevated FIB-4 levels have been independently associated with MI, particularly among females and individuals with concomitant hypertension. Consequently, the FIB-4 index is anticipated to serve as a promising tool for early detection and risk stratification in this population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1551472","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T05:18:35Z","timestamp":1741756715000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Cross-sectional study on the association between the fibrosis-4 index and co-occurring myocardial infarction in Chinese patients with type 2 diabetes mellitus"],"prefix":"10.3389","volume":"16","author":[{"given":"Ziyi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangjun","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenXi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuiwu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00113-3","article-title":"Treatment of type 2 diabetes: challenges, hopes, and anticipated successes","volume":"9","author":"Nauck","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.22208","article-title":"Prevalence and treatment of diabetes in China, 2013-2018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","article-title":"Diabetic vascular diseases: molecular mechanisms and therapeutic strategies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12933-024-02212-3","article-title":"Longitudinal blood glucose level and increased silent myocardial infarction: a pooled analysis of four cohort studies","volume":"23","author":"Xiao","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12933-022-01550-4","article-title":"Short and long-term prognosis of admission hyperglycemia in patients with and without diabetes after acute myocardial infarction: a retrospective cohort study","volume":"21","author":"Upur","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv Drug Delivery Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111652","article-title":"Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population","volume":"211","author":"Chew","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000735","article-title":"Metabolic dysfunction-associated steatotic liver disease and the heart","author":"Driessen","year":"2023","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0096","article-title":"The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease","volume":"28","author":"Ng","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100762","article-title":"Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis","volume":"28","author":"Muthiah","year":"2023","journal-title":"Ann Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14950","article-title":"Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarction","volume":"25","author":"Chin","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00017-1","article-title":"Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study","volume":"8","author":"Vali","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.016","article-title":"Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population","volume":"75","author":"Nielsen","year":"2021","journal-title":"J Hepatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"Electronic address: easloffice@easloffice.eu, Clinical Practice Guideline Panel, Chair: EASL Governing Board representative: Panel members: EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"s49","DOI":"10.2337\/dc23-S004","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13317","article-title":"Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction","volume":"8","author":"Nakashima","year":"2021","journal-title":"ESC Heart Failure"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211037239","article-title":"Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke","volume":"14","author":"Fandler-H\u00f6fler","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"B21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2020.03.010","article-title":"Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease","volume":"299","author":"Chen","year":"2020","journal-title":"Atherosclerosis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110206","article-title":"Fibrosis-4 stage of liver fibrosis predicts cardiovascular outcomes in acute coronary syndrome patients with and without type 2 diabetes mellitus","volume":"195","author":"Song","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1172178","article-title":"Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals: NHANES 1999\u20132008","volume":"10","author":"Guan","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B24","volume-title":"Diabetes Complications\u00a0Early Warning Dataset","year":"2022"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","article-title":"Heart disease and stroke statistics\u20132013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010171","article-title":"FIB-4 index and diabetes mellitus are associated with chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease","volume":"21","author":"Seko","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3758\/s13428-013-0329-y","article-title":"Subspace K-means clustering","volume":"45","author":"Timmerman","year":"2013","journal-title":"Behav Res Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12933-024-02144-y","article-title":"Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal glucose metabolism","volume":"23","author":"Min","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12933-023-02114-w","article-title":"Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China","volume":"23","author":"Li","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2337\/dc20-1997","article-title":"Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening","volume":"44","author":"LoMonaco","year":"2021","journal-title":"Diabetes Care"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154779","article-title":"The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis","volume":"120","author":"Liu","year":"2021","journal-title":"Metabolism"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence","volume":"68","author":"Lonardo","year":"2018","journal-title":"J Hepatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031230","article-title":"Immune activation mediates the association of advanced hepatic fibrosis with adverse outcomes in patients with coronary artery disease","volume":"12","author":"Jain","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metabolism"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100780","article-title":"Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and\/or type 2 diabetes: a longitudinal cohort study","volume":"36","author":"Anstee","year":"2024","journal-title":"Lancet Regional Health - Europe"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e018869","DOI":"10.1161\/JAHA.120.018869","article-title":"Liver fibrosis scoring systems as novel tools for predicting cardiovascular outcomes in patients following elective percutaneous coronary intervention","volume":"10","author":"Liu","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23960","article-title":"Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race","volume":"32","author":"Bril","year":"2024","journal-title":"Obes (Silver Spring)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13956","article-title":"Letter: changes in FIB-4 cut-off points for viral hepatitis","volume":"45","author":"Kayadibi","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00058.2021","article-title":"Surrogate scores of advanced fibrosis in NAFLD\/NASH do not predict mortality in patients with medium-to-high cardiovascular risk","volume":"321","author":"Delgado","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2023.100301","article-title":"Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation","volume":"78","author":"Tan","year":"2023","journal-title":"Clinics (Sao Paulo)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2014.01.014","article-title":"Angiogenesis, inflammation and endothelial function in postmenopausal women screened for the metabolic syndrome","volume":"77","author":"Chedraui","year":"2014","journal-title":"Maturitas"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1551472\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T05:18:39Z","timestamp":1741756719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1551472\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":41,"alternative-id":["10.3389\/fendo.2025.1551472"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1551472","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"article-number":"1551472"}}